title: Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs.
abstract: BACKGROUND
  Cholecystokinin (CCK) 58 is the predominant molecular form of CCK in canine and human intestine and circulating blood. There is no report on the metabolism and clearance rate of CCK-58. The aim of this study was to compare the in vivo half-life and metabolism of CCK-58 with that of synthetic CCK-8.
  
  
  METHODS
  CCK-58 was purified from canine intestine by consecutive high-performance liquid chromatographic (HPLC) and fast protein liquid chromatographic steps. The peptides were given to 12 dogs as an intravenous (IV) bolus injection to determine the half-life of circulating CCK. Six dogs were given CCK-58 or CCK-8 as a constant IV infusion to determine plasma clearance rates and stability in circulating blood. Circulating molecular forms of CCK were determined by radioimmunoassay after extraction of CCK from plasma and characterization by HPLC.
  
  
  RESULTS
  The half-life of CCK-58 was 4.4 +/- 0.6 minutes compared with 1.3 +/- 0.1 minutes for CCK-8. Less than 5% of CCK-58 could be detected as smaller forms during constant IV infusion.
  
  
  CONCLUSIONS
  The longer half-life of CCK-58 compared with CCK-8 and the minimal conversion into smaller forms during constant IV infusion are consistent with the finding that CCK-58 is not only the major stored form but also the circulating form of CCK after endogenous stimulation in dogs.
authors.affiliation: Division of Gastroenterology, University of Essen, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Hoffmann
authors.forename: G A
authors.initials: GA
authors.lastname: Eberlein
authors.forename: J R
authors.initials: JR
authors.lastname: Reeve
authors.forename: R H
authors.initials: RH
authors.lastname: Bünte
authors.forename: D
authors.initials: D
authors.lastname: Grandt
authors.forename: H
authors.initials: H
authors.lastname: Goebell
authors.forename: V E
authors.initials: VE
authors.lastname: Eysselein
mesh_terms: D000818:Animals; D002766:Cholecystokinin / Q000008:administration & dosage / Q000302:isolation & purification / Q000493:pharmacokinetics*; D004285:Dogs; D006207:Half-Life; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000737:chemistry; D008657:Metabolic Clearance Rate; D012844:Sincalide / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics*
chemical_list: C038823:cholecystokinin 58; D002766:Cholecystokinin; D012844:Sincalide